Skip to main content

Table 1 Clinical and anthropometric features of patients (n = 56) and controls (n = 26). Data are expressed as Mean +/- SD (min; max)

From: Increased levels of interleukin 31 (IL-31) in osteoporosis

 

Patients

Controls

Age (years)

65 +/- 9 (39; 80)

62 +/- 8 (48; 76)

Height (cm)

153 +/- 0.06 (135; 165)

152 +/- 0.05 (142; 159)

Weight (kg)

63.83 +/- 9.43 (51; 86)

64.73 +/- 11.06 (51; 83)

Body mass index (kg/m2)

26.88 +/- 4.49 (19.34; 34.78)

27.70 +/- 3.55 (22.5; 34.58)

Total hip BMD (g/cm2)*

0.701 +/- 0.07 (0.460; 0.790)

0.990 +/- 0.10 (0.890; 1.300)

Total hip T-score*

−3.0 +/- 0.7 (-5.4; -2.0)

−0.1 +/- 1.0 (-1.1; 3.0)

Total hip Z-score*

−1.1 +/- 0.9 (-3.3; 0.2)

1.4 +/- 1.1 (-0.5; 4.0)

Calcanear QUS T-score *

−3.6 +/- 0.92 (-5.5; -1.79)

−0.73 +/- 1.26 (-2.3; 2.5)

ESR (mm/h)*

19.25 +/- 8.69 (6; 44)

12 +/- 7.56 (2; 27)

CRP (mg/L)*

5.75 +/- 6.60 (0.1; 41)

2.67 +/- 3.65 (0.1; 19)

BAP (μg/L)

17.68 +/- 6.57 (8.2; 30.8)

15.26 +/- 7.00 (5; 30.8)

CTX (pg/mL)*

380 +/- 246 (0.32; 900)

155 +/- 236 (5; 568))

PTH (pg/mL)

67.03 +/- 22.59 (28.6; 147)

66.04 +/- 15.20 (42.5; 88)

  1. Legend: erythrocyte sedimentation rate (ESR); C-reactive protein (CRP); bone alkaline phosphatase (BAP)
  2. ; C-telopeptide cross-linked collagen type 1 (CTX); parathyroid hormone (PTH)
  3. *Statistically significant difference between patients and controls (p < 0.001)